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Abstract - The purpose of this study was to assess the test-retest stability of the Fager- 
Strom Tolerance Questionnaire (FTQ) in two samples: (a) paid subjects in an American 
laboratory; data were collected via telephone screen and subsequently via questions embed- 
ded in a written history; and (b) smokers hospitalized for depression in Paris: data were 
collected via a written questionnaire upon admission and again after 3 weeks of treatment for 
depression. Reliability data are also presented for a recently revised version of the FTQ, the 
Fagerstrom Test for Nicotine Dependence (FTND), and compared with FTQ data collected 
in a subsample of subjects in the American database who received both versions of the 
questionnaire. Both the FTQ (in both samples) and the FTND proved to be highly reliable. 
The validity of the scales, using cotinine, number of years smoked. and the “addictive” 
factor on the Classification of Smoking by Motives questionnaire as criterion variables. was 
also supported. No relationship between FTQ score and severity of depression was detected 
in either sample. Internal consistency was somewhat higher for the FTND than for the FTQ. 
replicating previous findings in the literature. 
What has come to be known as the Fagerstrom Tolerance Questionnaire (FTQ; 
Fagerstrom, 1978) was presented by the author as a test of “physical dependence to 
nicotine.” Although he reported validation of his instrument in small samples using 
as his touchstones change in body temperature following withdrawal in smokers and 
heart rate increment during smoking in both smokers and exsmokers, it is probably 
safe to say that the widespread use that followed, in both research and clinical 
settings, was due less to its superior psychometric properties than to the fact that it 
filled a “market niche,” at a time when the importance of nicotine dependence as an 
obstacle to quitting was becoming increasingly apparent and when pharmacothera- 
peutic approaches were starting to be developed. Its only “competitors” were ques- 
tionnaires such as the Reasons for Smoking Scale (Ikard & Tomkins, 1973; Tomkins, 
1966) and the Classification of Smoking by Motives (CSM; Russell, Peto, & Patel, 
1974), which were intended to categorize smokers - or more accurately, smoking 
behavior - on the basis of smoking motivation typology. Though some of the types 
discriminated (e.g., the CSM “addictive” smoking; Russell et al., 1974) might be 
thought of as tapping a similar construct, these scales, unlike the FTQ, were not 
explicitly intended to provide a continuum along which u/l smokers could be 
placed. 
Testing of the psychometric properties of the instrument has thus proceeded hap- 
hazardly, rather than systematically in different subject samples. Conspicuously 
lacking, for example, has been any attempt to establish the reliability of the scale. 
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Nevertheless, the FTQ has by and large acquitted itself fairly well (Fagerstrom & 
Schneider, 1989). having been demonstrated to predict such rncasures as cotininc 
(Pomerleau. Pomerleau. Majchrzak. Kloska. & Malakuti. 1990). CO (Fagerstrom, 
1982). nicotine boost upon smoking (Lombardo, Hughes. 81 Fross. 19x8). and suc- 
ccss in smoking cessation (Pinto, Abrams, Monti. & Jacobus, 1987). and to distin- 
guish between light and heavy smokers stratified on the basis ofcotinine (Pomcrleau. 
Fertig. & Shanahan. 1983). Over the years. however. a number of shortcomings have 
been identified, especially relating to internal consistency (Lichtenstcin & Mermcl- 
stein. 1986: Swan, Ward, & Jack, 1991) and to failure of some of the items to 
contribute to the predictive power of the test (Heatherton. Kozlowski. Frecker, & 
Fagerstrom, 1991). These objections have led to suggestions for refinement of indi- 
vidual items (Moore. Schneider. & Ryan. 1987; Pomerleau. MaJchrzak, & Pomcr- 
leau, 1989) and more recently to the proposal by Fagerstrom and a group of collabo- 
rators of a new version, the Fagcrstrom Test for Nicotine Dependence (FTND: 
Heatherton et al., 1991). 
The purpose of the present study was to fill a gap in the literature by determining 
the reliability of the FTQ in two different samples: (a) 237 smokers paid to participate 
in laboratory experiments in Ann Arbor. Michigan: data were collected via telephone 
screen and approximately 2 weeks later via questions embedded in a written history: 
and (b) 36 smokers hospitalized for depression in Paris; data were collected via a 
written questionnaire upon admission and again after 3 weeks of treatment for de- 
pression. Subjects in both samples were regular smokers who were not attempting to 
quit and who were not in treatment for smoking cessation. Reliability data are also 
presented for the FTND and compared with FTQ data collected in a subsample of 60 
subjects in the American database who received both versions of the questionnaire. 
Analyses of internal consistency, using Cronbach’s alpha, and external validity, 
using years smoked (associated with increases in intake: Russell. 1979). cotinine (a 
nicotine metabolitc that serves as a biological index of intake), and scores on the 
CSM “addictive’* factor (Russell et al., 1974) as criterion variables, are reported 
briefly. 
M E ‘I- H 0 D 
Subjects were drawn from two separate samples: (a) 237 smokers (43.5% female; 
age [M ? SD], 28.9 t 6.6 years), in good health (including no history of psychopa- 
thology) and not on psychoactive medications, who were paid to participate in 
experiments in our laboratory between 1986 and the present. A subsample of 60 
smokers (25.0% female; age 28.7 2 6.6 years) received the FTND as well. Although 
subject selection criteria varied across experiments. most were recruited for being 
moderate smokers who smoked at least I.5 cigarettes per day and who had smoked 
for at least 3 years, and for being in the 20 to 45 age range. (b) 36 smokers (66.7% 
female: age 36.3 2 9.6 years) meeting the DSM-III-R criteria of major depression, 
hospitalized in the Salpetriere Hospital (Paris). 
For the American laboratory sample. test-retest data were collected initially via 
telephone screen and subsequently (15.0 +- 31.3 days later) via questions embedded 
in a written history. More recently, sufficient data have been collected to permit 
calculation of scores for both the FTQ and the FTND. Also available for many of 
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these subjects were baseline cotinine levels assayed using HPLC (Hariharan, Van- 
Noord, & Greden, 1988), number of years smoked, and scores on the “addictive” 
scale of a brief version of the CSM (Russell et al., 1974) that includes only the three 
items that loaded highest on each factor and that retains the factor structure of the 
original (Tate, Pomerleau, & Pomerleau, in press). Because depression has 
been associated with smoking status (Glassman et al., 1990). we also included in 
our analyses scores on the Center for Epidemiological Studies Depression Scale 
(CES-D; Weissman, Sholomakis, Pottenger, Prushoff, & Locke, 1970). (Data 
were drawn from a database including baseline and demographic variables collected 
at screening or via take-home packets. Because these packets varied somewhat de- 
pending on the study and the time at which they were collected, data for some 
of the variables included as validators were not available for all subjects.) 
For the French sample, the FTQ was filled out as part of a battery of question- 
naires administered in the context of a study of smoking behavior in depressed 
subjects. Each subject was assessed upon admission, before administration of anti- 
depressant treatment and in some instances after a placebo wash-out period. An 
extensive psychiatric interview, including the Hamilton Rating Scale for Depression 
(HRSD; Hamilton, 1967), was conducted by an experienced clinician in order to 
evaluate intensity of symptomatology, following which patients were asked to com- 
plete the questionnaires. Subjects were reassessed just prior to discharge, when they 
were judged as normothymic by the clinicians, after at least 3 weeks’ antidepressant 
treatment; for the majority, assessment was made on Day 21. The procedure was 
identical to that at Day 0. The CSM was also administered; for comparability across 
the two samples, only the three items administered to the American sample were 
used. 
Validity data are presented only for the telephone screen data in the American 
sample and for the admission interview for the French sample. Results in both 
instances were similar for the second administration. 
RESULTS 
FTQ 
Test-retest correlations for the two samples, for both the full questionnaire and 
the individual items, are shown in Table I. No decrease in test-retest reliability was 
observed as a function of time elapsed between the two administrations in the Ameri- 
can sample, as determined by correlating the absolute difference between the two 
scores with the amount of time between administration (n = 196; I’ = -.lO, NS). 
In the American sample, there was a small but statistically significant decrease 
(t[236] = 5.23, p < .OOl) in FTQ scores between Time 1 (telephone screen; 7.3 ? 1.8) 
and Time 2 (written history; 6.9 5 2.0). Individual items that contributed signifi- 
cantly to this drop were item 1 (time to first cigarette), item 2 (forbidden cigarettes), 
item 3 (which cigarette would you most hate to give up?), and item 6 (smoke if ill). In 
the French sample, scores on the first administration (5.75 ? 2.3) did not differ 
significantly from scores on the second (6 ? 2.5), nor did any item score differ 
significantly between administrations. 
Cronbach’s alpha for our laboratory subjects has been previously reported (Pom- 
erleau et al., 1990); with the additional subjects in the current database, Cronbach’s 
alpha for the FTQ was .47. For the French sample, Cronbach’s alpha was .61. 
A significant correlation between cotinine and FTQ score in our laboratory sub- 
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Table I Test-retest correlation\ for total FTQ score and individual 
items in two simple\ 
American sample French ample 
(II = 137) (II = 36) 
FTQ (total) 
FTQI (time to It cigaretle) 
FTQ2 tforbidden cigarettes) 
FTQ3 (most hate to give up) 
FTQ4 (cigwetteslday) 
b’TQ5 (morning smoking) 
FTQ6 (smoke if ill) 
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jects has been previously reported (Pomerleau et al., 1990). This correlation has been 
sustained with the addition of more subjects to our database (n = 136: r = + .35, p < 
.OOl). Correlation with number of years smoked (1) = 214) was +.3X (p < .OOl). 
Scores on the CSM “addictive” factor were significantly correlated with FTQ in 
both the American sample (n = 216: I’ = +.40. p < .OOl) and in the French sample 
(n = 35; r = t.62, p < ,001). 
In the American sample (n = 183), no correlation was detected between CES-D 
and FTQ scores (r = +.02, NS). Likewise. in the French sample, no association was 
detected between FTQ score and severity of depression as measured by the HRSD 
(r = -.03. NS). 
FTND 
Test-retest correlations for both the FTQ and the FTND. in the subsample of 60 
who took both questionnaires, are shown in Table 2. There was no significant differ- 
ence between the first and second administration for either the FTQ (M ? SLI for first 
administration, 6.9 t 2.2; for second administration, 6.7 -C 2.1; t 1591 = .X3, NS) or 
the FTND (first administration, 5.3 * 2.4: second administration, 5.1 + 2.4: t [59] = 
1.44, NS). 
Cronbach’s alpha was .58 for the FTQ and .64 for the FTND. Correlation with 
cotininc (n = 27) was +.4S (p < .OS) for the FTQ and +.39 (p < .05) for the FTND. 
Correlation with number of years smoked was + .S7 (p < ,001) for the FTQ and + .52 
(p < .OOl) for the FTND. Correlation with the CSM “addictive” factor (n = 55) was 
+.S6 (p < .OOl) for the FTQ and +.S3 (p < ,001) for the FTND. No relationship with 
depression (n = 59) was detected for either the FTQ (r = -.18, NS) or the FTND 
(r = -.24. NS). 
D I S C U S S 1 0 N 
In both the American and French samples. the FTQ showed very satisfactory 
test-retest reliability. A high correlation emerged in the American sample despite 
the use of alternate forms (telephone vs. paper-and-pencil), which might be expected 
to attenuate the association. Individual items were also well-correlated. 
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Table 2. Test-retest correlations for FTQ and FTND scores (total 
and items in the same sample) 
Total 
Time to 1st cigarette 
Forbidden cigarettes” 
Most hate to give up” 
Cigarettes/day 
Morning smokingd 




(n = 60) (n = 60) 
+.KZ** +.882** 
+ .926** +.817** 
+ .493** +.493** 
+.665x* + .665** 
+ .892** + .970** 
+ .506** + .506** 
+ .629** +.629** 
+.727** - 
+ 1 .ooo** - 
“These items are used and scored identically in both questionnaires, 
**p < .OOl. 
The FTQ performed equally well in two samples that differed with respect to 
presence of depression and sociocultural factors. Of particular note is the difference 
in smoking rate, which is currently around 25% in the United States (National Health 
Interview Survey, 1991) and 40% in France (Molimard et al., 1992). In fact, smoking 
prevalence in France today is virtually identical to that in the United States in 1965, 
only a year after the Report of the Surgeon General’.s Advisory Committee on Smok- 
ing and Health (USPHS, 1964) publicizing the health hazards of smoking. In a 
society in which smoking is not seriously discouraged, one would expect considera- 
bly more “discretionary” smoking than in a society characterized by extensive 
public health campaigns and social sanctions. Our findings thus suggest that the FTQ 
is potentially useful in a broad spectrum of populations. 
A small but consistent decrease in score between the first and second administra- 
tion occurred in the American, but not in the French, sample. A possible explanation 
is that, because our subjects were recruited for being moderately dependent, the 
change simply represents regression to the mean. It is also possible, however, that 
the use of alternate forms influenced test results. 
Although the nature of the relationship between depression and degree of depen- 
dence remains to be delineated, our results suggest that treatment of depression does 
not affect the reliability of the FTQ. 
Test-retest reliability of the FTND was as good as or better than that of the FTQ. 
We likewise replicated Heatherton et al.‘s (1991) results showing a somewhat higher 
Cronbach’s alpha in the FTND than in the FTQ when calculated in the same group of 
subjects. Our rough measures of external validity, however, did not demonstrate any 
clearcut superiority for the FTND in this relatively small sample. 
It should be noted that one of the problems relating to validation of either the FTQ 
or the FTND is the lack of either “hard” (biological) measures of dependence or a 
universally agreed-upon set of criteria that would allow us, say, to comment on the 
sensitivity and specificity of the test, or to establish cutoffs for what Shiffman (e.g., 
1990) has referred to as nondependent smokers. In fact, we may be demanding more 
of the test, in terms of internal consistency and construct validity, than we demand 
of the concept of “physical dependence” itself - because there is no clearcut evi- 
dence that chronic tolerance (both pharmacokinetic and pharmacodynamic), acute 
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tolerance, withdrawal symptomatology, drug self-administration (as measured by 
intake), etc., are unidimensional. The price we pay for achieving a “homogeneous 
set” of questions (Heatherton et al., IWl), for example, may be a loss of information 
about actual drug intake; and though no one would argue that intake and dependence 
are coterminous, it would be equally rash to say that strength of drug-seeking behav- 
ior is irrelevant to dependence. An extensive consideration of the nature of depen- 
dence is outside the scope of this article; our point is that major improvements in the 
test will probably follow rather than precede refinements in our understanding of 
dependence itself. Meanwhile, we may sometimes find ourselves in the position of 
defining nicotine dependence (to paraphrase an only partly facetious definition of 
another elusive concept, intelligence) as “that which the FTND measures.” 
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